For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The North America stem cell market is estimated to grow at a CAGR of 9.44% during the forecast period of 2019-2027. The government's subsidy and sustenance in the field of stem cell market, increasing investments in R&D and surge in neurodegenerative ailments are some of the factors driving the stem cell market.
Stem cell market is segmented by products, treatment type, technology, therapeutic application, and applications. The United States and Canada are the two key countries in the North American market. The United States has captured a significant share of North America's stem cell market, and it is expected to be the largest market in the region. The rise in the number of cancer cases is significantly driving this market's growth. The United States is well known for its advanced healthcare infrastructure. However, stringent government regulations are hampering the market growth.
Companies like Corning Inc., Biotime Inc., Stryker Corporation, Qiagen N.V., Vericel Corporation (formerly Aastrom Bioscience), Cytori Therapeutics, Cellular Dynamics International (Holding Company Fujifilm), Cellular Engineering Technologies, Inc., Celgene Corporation, Pluristem Therapeutics Inc., GE Healthcare, Brainstorm Cell Therapeutics, Becton Dickinson And Company, International Stem Cell Corp., Thermo Fisher, Fibrocell Science Inc., StemCell Technologies, Stemedica Cell Technologies Inc., and Takara Holdings Inc. are operating in this region.